阿匹莫德

Apilimod

未知生产厂商

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

适应症

Investigated for use/treatment in crohn's disease and psoriasis and psoriatic disorders.

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

COMBINATION THERAPY WITH APILIMOD AND GLUTAMATERGIC AGENTS
EP 3755332 A1申请人: AI THERAPEUTICS INC优先权: 2018
CN
EP
US
5 件公开
STABILIZED APILIMOD COMPOSITIONS AND USES THEREOF
US 20240374523 A1申请人: ORPHAI THERAPEUTICS INC优先权: 2021
CN
US
4 件公开
APILIMOD FOR USE IN THE TREATMENT OF COLORECTAL CANCER
EP 3954375 A1申请人: AI THERAPEUTICS INC优先权: 2014
CN
EP
US
3 件公开
Apilimod for use in the treatment of renal cancer
US 10206910 B2申请人: LAM THERAPEUTICS INC优先权: 2014
CN
US
3 件公开
APILIMOD COMPOSITIONS AND METHODS OF USE
- US 2024024332 A1
  申请人: AI THERAPEUTICS INC优先权: 2023
  US
  3 件公开
- EP 4753717 A1
  申请人: ORPHAI THERAPEUTICS INC优先权: 2023
  EP
  WO
  2 件公开
Methods for treating cancer using apilimod
US 10350213 B2申请人: AI THERAPEUTICS INC优先权: 2015
CN
US
2 件公开
Apilimod compositions and methods for using same
US 10179135 B2申请人: LAM THERAPEUTICS INC优先权: 2015
US
2 件公开
BIOMARKERS FOR TREATING CANCER WITH APILIMOD
CN 108495633 A申请人: LAM THERAPEUTICS INC优先权: 2016
CN
Anti-viral compositions containing PIKfyve inhibitors and use thereof
US 10729694 B2申请人: AI THERAPEUTICS INC优先权: 2016
US
APILIMOD COMPOSITIONS AND METHODS FOR USING SAME IN THE TREATMENT OF ALZHEIMER'S DISEASE
CN 110167559 A申请人: AI THERAPEUTICS INC优先权: 2016
CN